Page last updated: 2024-08-26

methyllycaconitine and Shock, Septic

methyllycaconitine has been researched along with Shock, Septic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cai, GJ; Chen, AF; Kong, Y; Le, YY; Liu, C; Liu, X; Shen, FM; Su, DF	1

Other Studies

1 other study(ies) available for methyllycaconitine and Shock, Septic

Article	Year
Antishock effect of anisodamine involves a novel pathway for activating alpha7 nicotinic acetylcholine receptor. Critical care medicine, 2009, Volume: 37, Issue:2 Topics: Aconitine; alpha7 Nicotinic Acetylcholine Receptor; Animals; Base Sequence; Cell Line; China; DNA Primers; Interleukin-1beta; Macrophages, Peritoneal; Mice; Nicotinic Agonists; Nicotinic Antagonists; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Shock, Septic; Solanaceous Alkaloids; Tumor Necrosis Factor-alpha; Vagotomy	2009

Article

Year

Antishock effect of anisodamine involves a novel pathway for activating alpha7 nicotinic acetylcholine receptor.

Critical care medicine, 2009, Volume: 37, Issue:2

Topics: Aconitine; alpha7 Nicotinic Acetylcholine Receptor; Animals; Base Sequence; Cell Line; China; DNA Primers; Interleukin-1beta; Macrophages, Peritoneal; Mice; Nicotinic Agonists; Nicotinic Antagonists; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Shock, Septic; Solanaceous Alkaloids; Tumor Necrosis Factor-alpha; Vagotomy

2009